TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.00
-0.48 (-8.76%)
At close: May 30, 2025, 4:00 PM
5.25
+0.25 (5.00%)
After-hours: May 30, 2025, 7:02 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $189.19 million as of May 30, 2025. Its market cap has decreased by -30.34% in one year.
Market Cap
189.19M
Enterprise Value
209.31M
1-Year Change
-30.34%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $189.19M, a decrease of -42.45%. That is a compound annual growth rate of -12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 161.36M | 5.62% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |